Implementation of concomitant Impella® support
Impella® (Abiomed, Danvers, Massachusetts, USA) implantation was
realized either simultaneously with VA-ECMO in the heart catheter
laboratory or after ECMO implantation on the intensive care unit, due to
clinical findings as mentioned above.
- End diastolic LV-size (LVEDD) ≥ 6.8cm (male), 6.1cm (female)
- spontaneous contrast in TTE/TEE
- Reticular lung edema in chest x-ray
Impella® implantation was guided by transoesophageal echocardiography.
Additional Impella® therapy resulted in a target ACT of 180-220.